Improving Management of Patients at High Risk for Osteoporotic Fractures - Article
Clinical Trial: Improving Management of Patients at High Risk for Osteoporotic Fractures
This study is no longer recruiting patients.
|Osteoporosis || Behavior: Disease Management Assessment |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Dose Comparison, Parallel Assignment
Secondary Outcomes: Osteoporosis medication treatment rates and medication
Expected Total Enrollment: 9369
Study start: September 2004
- Members of the Horizon Blue Cross who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).
- Individuals who are not members of Horizon Blue and who otherwise do not meet the inclusion criteria.
Medical Monitor, Study Director, Merck
Last Updated: September 7, 2005
Record first received: August 29, 2005
ClinicalTrials.gov Identifier: NCT00139438
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13